Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Elicera Therapeutics AB
ELICCurrent price
1.79 SEK
-0.056 SEK (-2.99%)
Last closed
1.85 SEK
Company
www.elicera.com
ISIN
SE0015382080
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
65 913 717 SEK
Yield for 12 month
-60.94 %
1Y
3Y
5Y
10Y
15Y
ELIC
Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/IIa clinical trial for neuroendocrine tumors; and ELC-201, which is in preclinical stage for the treatment of various forms of solid cancer. It is also developing ELC-301, a CAR T-cell therapy that is in Phase I/IIa clinical trial for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy, which is in preclinical stage for the treatment of brain tumors. Elicera Therapeutics AB (publ) has collaboration with the Vecura R&D division at Karolinska University Hospital and Uppsala University to develop a fully automated production flow of ELC-401 for use in future clinical trials. The company was incorporated in 2014 and is based in Gothenburg, Sweden. Address: World Trade Centre Gothenburg, Gothenburg, Sweden, 412 51
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
26.46 SEKP/E ratio
–Dividend Yield
–Current Year
+11 340 204 SEK
Last Year
+1 292 727 SEK
Current Quarter
+998 403 SEK
Last Quarter
+3 064 809 SEK
Current Year
+11 340 204 SEK
Last Year
+1 280 842 SEK
Current Quarter
+995 426 SEK
Last Quarter
+3 061 833 SEK
Key Figures ELIC
1 year
3 years
5 years
10 years
EBITDA
-21 839 398 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.12 %
PEG Ratio
–
Return On Equity TTM
-79.82 %
Wall Street Target Price
26.46 SEK
Revenue TTM
12 189 617 SEK
Book Value
0.75 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-44.2 %
Dividend Yield
–
Gross Profit TTM
1 292 728 SEK
Earnings per share
-0.9 SEK
Diluted Eps TTM
-0.9 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-172.21 %
Dividend Analytics ELIC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ELIC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ELIC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
66173.4191
Price Sales TTM
5.4074
Enterprise Value EBITDA
-2.2144
Price Book MRQ
2.5214
Financials ELIC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ELIC
For 52 weeks
0.86 SEK
5.74 SEK
50 Day MA
1.7 SEK
Shares Short Prior Month
–
200 Day MA
1.6 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart